Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Agnelli

Showing results (11-20 of 111) with videos related to

Pageof 12
Sort By:
Experimental Hematology|November 18, 2008
Identification of primary MAFB target genes in multiple myelomaEsther van Stralen, Marc van de Wetering, Luca Agnelli, et al.
Hematological Oncology|October 13, 2006
Relevance of Ras gene mutations in the context of the molecular heterogeneity of multiple myelomaDaniela Intini, Luca Agnelli, Gabriella Ciceri, et al.
British Journal of Haematology|October 4, 2005
Transcription repression activity is associated with the type I isoform of the MMSET gene involved in t(4;14) in multiple myelomaKatia Todoerti, Domenica Ronchetti, Luca Agnelli, et al.
Genes, Chromosomes & Cancer|March 24, 2009
Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profilesMarta Lionetti, Luca Agnelli, Laura Mosca, et al.
Blood Cancer Journal|February 21, 2019
Expanding the repertoire of miRNAs and miRNA-offset RNAs expressed in multiple myeloma by small RNA deep sequencingLuca Agnelli, Andrea Bisognin, Katia Todoerti, et al.
Experimental Hematology|October 28, 2010
The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxideManuela Abeltino, Sabrina Bonomini, Marina Bolzoni, et al.
Experimental Hematology|November 27, 2012
Immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and the RANKL/OPG ratio in the myeloma microenvironment targeting the expression of adhesion moleculesMarina Bolzoni, Paola Storti, Sabrina Bonomini, et al.
Plos One|September 13, 2011
Impact of host genes and strand selection on miRNA and miRNA* expressionMarta Biasiolo, Gabriele Sales, Marta Lionetti, et al.
Genes, Chromosomes & Cancer|September 8, 2007
Molecular and transcriptional characterization of the novel 17p11.2-p12 amplicon in multiple myelomaSonia Fabris, Katia Todoerti, Laura Mosca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2011
The reconstruction of transcriptional networks reveals critical genes with implications for clinical outcome of multiple myelomaLuca Agnelli, Mattia Forcato, Francesco Ferrari, et al.
Pageof 12

Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
Experimental Hematology|November 18, 2008
Identification of primary MAFB target genes in multiple myelomaEsther van Stralen, Marc van de Wetering, Luca Agnelli, et al.
Hematological Oncology|October 13, 2006
Relevance of Ras gene mutations in the context of the molecular heterogeneity of multiple myelomaDaniela Intini, Luca Agnelli, Gabriella Ciceri, et al.
British Journal of Haematology|October 4, 2005
Transcription repression activity is associated with the type I isoform of the MMSET gene involved in t(4;14) in multiple myelomaKatia Todoerti, Domenica Ronchetti, Luca Agnelli, et al.
Genes, Chromosomes & Cancer|March 24, 2009
Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profilesMarta Lionetti, Luca Agnelli, Laura Mosca, et al.
Blood Cancer Journal|February 21, 2019
Expanding the repertoire of miRNAs and miRNA-offset RNAs expressed in multiple myeloma by small RNA deep sequencingLuca Agnelli, Andrea Bisognin, Katia Todoerti, et al.
Experimental Hematology|October 28, 2010
The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxideManuela Abeltino, Sabrina Bonomini, Marina Bolzoni, et al.
Experimental Hematology|November 27, 2012
Immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and the RANKL/OPG ratio in the myeloma microenvironment targeting the expression of adhesion moleculesMarina Bolzoni, Paola Storti, Sabrina Bonomini, et al.
Plos One|September 13, 2011
Impact of host genes and strand selection on miRNA and miRNA* expressionMarta Biasiolo, Gabriele Sales, Marta Lionetti, et al.
Genes, Chromosomes & Cancer|September 8, 2007
Molecular and transcriptional characterization of the novel 17p11.2-p12 amplicon in multiple myelomaSonia Fabris, Katia Todoerti, Laura Mosca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2011
The reconstruction of transcriptional networks reveals critical genes with implications for clinical outcome of multiple myelomaLuca Agnelli, Mattia Forcato, Francesco Ferrari, et al.
Pageof 12